| Literature DB >> 23383298 |
Lydie Michaillat1, Andreas Mayer.
Abstract
The equilibrium of membrane fusion and fission influences the volume and copy number of organelles. Fusion of yeast vacuoles has been well characterized but their fission and the mechanisms determining vacuole size and abundance remain poorly understood. We therefore attempted to systematically characterize factors necessary for vacuole fission. Here, we present results of an in vivo screening for deficiencies in vacuolar fragmentation activity of an ordered collection deletion mutants, representing 4881 non-essential genes of the yeast Saccharomyces cerevisiae. The screen identified 133 mutants with strong defects in vacuole fragmentation. These comprise numerous known fragmentation factors, such as the Fab1p complex, Tor1p, Sit4p and the V-ATPase, thus validating the approach. The screen identified many novel factors promoting vacuole fragmentation. Among those are 22 open reading frames of unknown function and three conspicuous clusters of proteins with known function. The clusters concern the ESCRT machinery, adaptins, and lipases, which influence the production of diacylglycerol and phosphatidic acid. A common feature of these factors of known function is their capacity to change membrane curvature, suggesting that they might promote vacuole fragmentation via this property.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23383298 PMCID: PMC3562189 DOI: 10.1371/journal.pone.0054160
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1The in vivo fragmentation assay under screening conditions.
(A) The cells were grown overnight in 96-well plates in HC-Leu- medium to an OD600<2. They were diluted 10-fold in YPD, stained with 20 µM FM4-64 for 1 hour, centrifuged and resuspended in YPD, HC or YPD diluted 5-fold with water (diluted YPD). After shaking for 2 hrs at 27°C, cells were transferred into optical 96-well plates. Fragmentation was induced by supplementing the suspension with 0.4 M NaCl. After 10 min of incubation at room temperature, cells were analyzed by fluorescence microscopy. Note that the screen was performed on a non-confocal microscope. Fragmentation was easier to judge on the microscope than on the photos, due to the possibility to focus through the sample in the z-direction. (B) Examples illustrating the scoring of the fragmentation defect. Samples sho pictures from cells after incubation with salt as in A.
Open reading frames of unknown function.
| ORF | Gene name(s) | Score |
| YKL061W | BLI1 | 3.0 |
| YLR358C | 3.0 | |
| YNL324W | 2.8 | |
| YPR116W | RRG8 | 2.5 |
| YDR509W | 2.3 | |
| YJR061W | 2.3 | |
| YDR215C | 2.0 | |
| YLR169W | 2.0 | |
| YOR302W | 2.0 | |
| YDL151C | BUD30 | 2.0 |
| YEL072W | RMD6 | 2.0 |
| YML002W | 1.8 | |
| YMR003W | AIM34 | 1.8 |
| YCR102W-A | 1.8 | |
| YGR160W | 1.8 | |
| YHR151C | MTC6 | 1.8 |
| YLR415C | 1.8 | |
| YLR422W | 1.8 | |
| YNL228W | 1.8 | |
| YLR235C | 1.7 | |
| YOR024W | 1.7 | |
| YPR099C | 1.7 |
Figure 2Phenotype of mutants in the PI(3,5)P2 pathway under screening conditions.
(A) BY4741 Δfab1 and BY4741 Δfig4 cells were cultivated and subjected to vacuole fragmentation under screening conditions in diluted YPD. Pictures show an overlay of the fluorescence and brightfield channels. (B) Metabolic pathways leading to the synthesis of PI(3,5)P2. Steps for which a gene deletion led to strong or moderate deficiency in vacuole fragmentation are indicated in red/bold.
Identified mutants affecting processes known to be involved in vacuole fragmentation: PI(3,5)P2 metabolism, vacuole acidification and TOR signaling.
| ORF | Gene name(s) | Function | Score |
| YFR019W | FAB1 | PI(3)P kinase, vacuolar sorting and vacuole homeostasis | 2.3 |
| YNL325C | FIG4 | PI(3,5)P2 phosphatase, response to osmotic shock, regulation of vacuole size | 2.8 |
| YLR386W | VAC14 | Regulates synthesis of PI(3,5)P2, vacuolar sorting, vacuole homeostasis | 2.0 |
| YFR021W | ATG18 | Binds PI(3,5)P2 and regulates FAB1 activity | 2.5 |
| YLR360W | VPS38 | Subunit of PI-3-kinase complex II | 2.3 |
| YKL135C | APL2 | β-subunit of AP-1 complex; mutation reduces PI(3,5)P2 | 3.0 |
| YBR127C | VMA2 | Subunit B of the V-ATPase | 2.0 |
| YLR447C | VMA6 | Subunit d of the V-ATPase | 1.3 |
| YJR066W | TOR1 | Subunit of TORC1 | 1.5 |
| YDL047W | SIT4 | Ser/Thr phosphatase | 1.3 |
Mutants related to vacuolar function, biogenesis and inheritance.
| ORF | Gene name(s) | Function | Score |
|
| |||
| YOR036W | PEP12 | t-SNARE in Golgi-to vacuole transport | 1.7 |
| YML097C | VPS9 | GEF for Rab-GTPase Vps21 | 2.8 |
| YOR089C | VPS21 | Rab GTPase, vacuolar hydrolases sorting | 1.5 |
| YJR126C | VPS70 | Vacuolar trafficking of Prc1p | 1.5 |
| YDR495C | VPS3 | CORVET complex | 1.7 |
| YAL002W | VPS8 | CORVET complex | 2.0 |
| YGR206W | MVB12 | ESCRT-I subunit | 3.0 |
| YPL065W | VPS28 | ESCRT-I-subunit | 1.6 |
| YPL002C | SNF8 | ESCRT-II subunit, glucose de-repression | 1.8 |
| YLR417W | VPS36, VAC3 | ESCRT-II subunit, vacuole inheritance | 2.7 |
| YLR025W | SNF7 | ESCRT-III subunit | 2.0 |
| YPL084W | BRO1 | Ubiquitin hydrolase in MVBs; | 1.8 |
| SNF7 interactor | |||
| YKR035W-A | DID2 | ESCRT-III dissociation; Vps4 interactor | 1.3 |
| YLR181C | VTA1 | Protein sorting at MVBs; Vps4 interactor | 1.8 |
| YDR486C | VPS60 | Late endosome to vacuole transport; Vta1 interactor | 1.8 |
|
| |||
| YML001W | YPT7 | Rab GTPase, vacuole fusion | 1.6 |
| YER123W | YCK3 | Vacuole fusion during hypertonic stress | 1.3 |
| YLR396C | VPS33 | SM-protein for vacuole fusion, HOPS-complex | 1.8 |
|
| |||
| YOR087W | YVC1 | Vacuolar cation channel | 1.5 |
| YHR028C | DAP2 | Di-peptidyl aminopeptidase | 1.5 |
| YJR001W | VMR1 | Vacuolar ABC transporter | 1.8 |
| YDR128W | SEA3 | SEA complex; associates with vacuoles | 1.8 |
Identified mutants with strong defects.
| Family of genes | Strong defect, score: [1.6–2] | Very strong defect, score: [2–3.5] |
|
| ||
|
| BRO1, YCK1, VTA1, SNF8, VPS60, VPS6, GGA2, VPS3,VPS28, GIC1, VPS33, YPT7, SEA3, JJJ1 | MVB12, VPS9, VPS36, SNF7, VPS29, VMA2, PAC11,VPS55, VPS8 |
|
| APL4, APS1, YAP1801 | APL2, APS3 |
|
| VMR1, PPZ1 | |
|
| TGL5, PLB1, PLB2 | FIG4, ATG18, FAB1, VAC14, VPS38, APQ12 |
|
| ||
|
| PDR8, CDC73, DIA2, MOT3, CHL1, SPT10 | RSC2, SPT7, NOT5, RAD7, RPA12, RPC53, HTL1,UME6, URE2 |
|
| HEK2, BRR1, DHH1 | NUP133, APQ12 |
|
| NDJ1, SNF4, MBP1, NSR1 | CLB2, MEK1, BUR2, FPR1, EGO3, TPK2 |
|
| GTT1, BNA1, APA1 | GAS5, ADH1, FYV9, GNP1, OSM1, RIB4, CPA1 |
|
| NTA1, UBR1, ULA1 | UMP1 |
|
| DIC1, ISU2, MDM1, COX6, MPRS8, MIC17, MRH4, AEP3,RPO41 | MSR1, MRPS35, MRPL17, MRP7, RSM22 |
|
| RPS24A, RPS4A, RPS1A, RPS1B | RPS7A, RPL41B, RPS30A |
|
| PEX15, PDR11, AHA1, SOL3 | PEX28, YKE4 |
|
| YML002W, YMR003W, YDL151C, YCR102W-A, YGR160W, YHR151C, YLR415C, YLR422W, YNL228W, YLR235C,YOR024W, YPR099C | YKL061W, YLR358C, YNL324W, YPR116W, YDR509W, YJR061W, YDR215C, YLR169W, YOR302W, YEL072W |
Identified mutants in triglyceride metabolism.
| ORF | Gene name(s) | Function | Score |
| YMR008C | PLB1 | Phospholipase B | 1.6 |
| YMR006C | PLB2 | Phospholipase B | 1.8 |
| YOL011W | PLB3 | Phospholipase B | 1.5 |
| YOR081C | TGL5 | Triacylglycerol lipase preferring VLCFAs; acyltransferase activity | 1.8 |
| YDR058C | TGL2 | Acylglycerol lipase | 1.5 |
| YIL040W | APQ12 | Unknown; mutant accumulates triglycerides | 2.0 |
| YOR084W | LPX1 | Putative lipase | 1.5 |
| YDR503C | LPP1 | Lipid phosphate phosphatase | 1.0 |
| YDL052C | SLC1 | Lyso-PA acyl transferase | 1.3 |
| YNR008W | LRO1 | Acyl transferase | 1.3 |
Figure 3Mutants in pathways converging on dicacylglycerol and phosphatidic acid.
(A) Phenotype of mutants related to triglyceride metabolism under screening conditions. Cells of the indicated mutants were grown and subjected to vacuole fragmentation as in Figure 1. Pictures show an overlay of the fluorescence and brightfield channels. (B) Scheme of pathways leading to the generation of diacylglycerol (DAG) and phosphatidic acid (PA). PC, phosphatidylcholine; PI, phosphatidylinositol; GroPCho, glycerophosphocholine; GroPIns, glycerophosphoinositol; Gro-3-P, glycerol-3-phosphate; DHAP, dihydroxyacetone phosphate; FA, fatty acids; TAG, triacylglycerol. Steps for which a deletion mutant results in strong or moderate fragmentation deficiency are indicated in red/bold.
Adaptin- and cytoskeleton-related mutants.
| ORF | Gene name(s) | Function | Score | |
| YKL135C | APL2 | β-subunit of AP-1 complex | 3.0 | |
| YPR029C | APL4 | γ-subunit of AP-1 complex | 1.8 | |
| YLR170C | APS1 | σ-subunit of AP-1 complex | 1.7 | |
| YPL195W | APL5 | ∂-Subunit of AP-3 complex | 1.5 | |
| YJL024C | APS3 | σ-Subunit of AP-3 complex | 2.0 | |
| YDR488C | PAC11 | Dynein intermediate chain | 2.0 | |
| YHR161C | YAP1801 | Clathrin cage assembly | 1.7 | |
| YHR135C | YCK1 | Septin assembly, endocytosis | 1.8 | |